tiprankstipranks
Trending News
More News >
Greenwich LifeSciences (GLSI)
NASDAQ:GLSI
US Market
Advertisement

Greenwich LifeSciences (GLSI) Financial Statements

Compare
384 Followers

Greenwich LifeSciences Financial Overview

Greenwich LifeSciences's market cap is currently $134.75M. The company's EPS TTM is $-1.208; its P/E ratio is ―; Greenwich LifeSciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -3.61K$ -3.61K$ -3.61K$ -3.61K
Operating Income$ -16.01M$ -9.33M$ -8.04M$ -4.60M$ -1.86M
EBITDA$ -15.79M$ -9.32M$ -8.04M$ -4.59M$ -1.86M
Net Income$ -15.79M$ -8.89M$ -7.61M$ -4.54M$ -1.86M
Balance Sheet
Cash & Short-Term Investments$ 4.09M$ 6.99M$ 13.47M$ 27.20M$ 28.66M
Total Assets$ 4.09M$ 6.99M$ 13.48M$ 27.22M$ 28.68M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00-
Net Debt$ -4.09M$ -6.99M$ -13.47M$ -27.20M-
Total Liabilities$ 1.56M$ 294.41K$ 262.90K$ 385.17K$ 1.05M
Stockholders' Equity$ 2.53M$ 6.70M$ 13.21M$ 26.83M$ 27.63M
Cash Flow
Free Cash Flow$ -7.27M$ -6.48M$ -6.20M$ -4.29M$ -1.15M
Operating Cash Flow$ -7.27M$ -6.48M$ -6.20M$ -4.29M$ -1.15M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 4.37M$ 0.00$ -7.54M$ 2.84M$ 29.81M
Currency in USD

Greenwich LifeSciences Earnings and Revenue History

Greenwich LifeSciences Debt to Assets

Greenwich LifeSciences Cash Flow

Greenwich LifeSciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis